Starfill Dermal Fillers — JETEMA ZEEP™ Technology HA — 1.1ml
- JETEMA ZEEP™ Technology — 24 mg/mL HA + 0.3% lido
- Ultra-low endotoxin <0.05 EU/mL, BDDE <0.5 ppm
- Three variants: Plus, Deep Plus, Implant Plus
- For licensed professionals only
| 1 – 2 boxes | $40.60 / box |
| 3 – 9 boxes | $38.57 / box |
| 10 – 19 boxes | $36.54 / box |
| 20 – 29 boxes | $35.32 / box |
| 30+ boxes | Contact for quote |
What Is Starfill Dermal Fillers — JETEMA ZEEP™ Technology HA — 1.1ml?
**Starfill** is a three-variant Korean HA dermal filler series manufactured by JETEMA Co., Ltd., utilizing proprietary ZEEP™ (Zero Endotoxin and BDDE Entire Process) technology to deliver 24 mg/mL cross-linked hyaluronic acid with 0.3% lidocaine, ultra-low endotoxin (<0.05 EU/mL), and residual BDDE below 0.5 ppm for professional facial contouring and volumization.
Starfill combines JETEMA's ZEEP™ purification technology with 24 mg/mL cross-linked HA to deliver ultra-pure dermal fillers with endotoxin levels below 0.05 EU/mL and residual BDDE under 0.5 ppm — among the lowest purification standards in the industry. Three viscoelasticity tiers (Plus, Deep Plus, Implant Plus) are differentiated by cross-linking degree and particle size (200–500μm), offering precise depth matching from superficial dermis to supraperiosteal placement with results lasting 6–18 months.
Specifications
| Product name | Starfill Dermal Fillers — ZEEP™ Technology HA Filler |
|---|---|
| Active ingredient | Cross-linked HA 24 mg/mL + Lidocaine 0.3% |
| Volume | 1 × 1.1ml pre-filled syringe |
| Endotoxin level | <0.05 EU/mL |
| BDDE residue | <0.5 ppm |
| Gel structure | Monophasic, uniform particle size 200–500μm |
| Application | Intradermal to supraperiosteal per variant |
| Treatment areas | Fine lines, periorbital, perioral, NLF, lips, cheeks, chin, jawline, temple, nose |
| Origin | South Korea (JETEMA Co., Ltd.) |
| Certification | KFDA, CE, ISO 13485 |
| Storage | 2–25°C, do not freeze, protect from direct sunlight |
| Shelf life | 24 months unopened |
Key Benefits
- ZEEP™ full-process purification delivers industry-leading purity with <0.05 EU/mL endotoxin and <0.5 ppm BDDE
- Three viscoelasticity tiers (G' up to 120 Pa) cover all dermal depths from superficial lines to supraperiosteal volumization
- Uniform monophasic gel with 200–500μm particle size ensures smooth, natural tissue integration
- 24 mg/mL HA concentration with 6–9% cross-link density provides durable results lasting 6–18 months
- Room-temperature stable storage (2–25°C) simplifies inventory management without cold-chain requirements
Suggested Treatment Protocol
Treatment protocol varies by variant. Starfill Plus is injected into the superficial-to-mid dermis using a 30G needle for fine lines and perioral areas. Starfill Deep Plus targets the mid-to-deep dermis with a 27G needle for nasolabial folds and lip augmentation. Starfill Implant Plus is placed in the deep dermis, subcutaneous plane, or supraperiosteally using 27G needles for volumetric correction of cheeks, chin, and jawline. A full treatment plan of 1–3 sessions with 4–8 week intervals is recommended. The exact injection depth, volume, and treatment schedule should be determined by the treating practitioner based on individual patient anatomy and aesthetic goals.
Premium quality filler. Best in class for this category.
Outstanding quality. Highly recommend for professional use.
Good product. The lidocaine makes a difference for patient comfort. Our clinic will be ordering more.
Decent product for the price point. Does what it's supposed to do.
Fast delivery and good communication. Product matches the description. Happy with the purchase.
Please log in to leave a review.